Discovering MicroRNAs from deep sequencing data using MiRDeep

Max Delbrück Centrum für Molekulare Medizin, Robert-Rössle-Strasse 10, D-13125 Berlin-Buch, Germany.
Nature Biotechnology (Impact Factor: 41.51). 05/2008; 26(4):407-15. DOI: 10.1038/nbt1394
Source: PubMed


The capacity of highly parallel sequencing technologies to detect small RNAs at unprecedented depth suggests their value in systematically identifying microRNAs (miRNAs). However, the identification of miRNAs from the large pool of sequenced transcripts from a single deep sequencing run remains a major challenge. Here, we present an algorithm, miRDeep, which uses a probabilistic model of miRNA biogenesis to score compatibility of the position and frequency of sequenced RNA with the secondary structure of the miRNA precursor. We demonstrate its accuracy and robustness using published Caenorhabditis elegans data and data we generated by deep sequencing human and dog RNAs. miRDeep reports altogether approximately 230 previously unannotated miRNAs, of which four novel C. elegans miRNAs are validated by northern blot analysis.

Download full-text


Available from: Catherine Adamidi
  • Source
    • "The remaining unique small RNA sequences were mapped to miRBase, and matched sequences were counted as known miRNAs. Mirdeep was used to identify novel miRNAs from unannotated sequences [20] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Immune thrombocytopenia (ITP), also known as idiopathic thrombocytopenic purpura, is an autoimmune disease characterized by low platelet count and increased bleeding tendency. Currently, glucocorticoid and splenectomy are the main therapies for ITP but with obvious side effects including tendency of relapse and risk of internal bleeding. In this study, we report the Mongolian medicine Qishunbaolier (QSBLE) can significantly and efficiently increase platelet count with a low recurrent rate and unnoticeable side effect. We profiled the microRNA (miRNA) expression in the blood sample of ITP patients and identified 44 miRNAs that are differentially expressed in ITP patients before and after QSBLE treatment. Out of these 44 miRNAs, 25 are expressed in control subjects and are downregulated in ITP patients, whereas the treatment with QSBLE restores their expressions to the level of control subjects. This result suggests that abnormal expression of these 25 miRNAs might be connected to the pathogenesis of ITP. Interestingly, 14 of those 44 miNRAs are predicted to target at least once on 31 known IPT associated genes, indicating the possible mechanism of QSBLE on ITP therapy.
    Full-text · Article · Aug 2015 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • Source
    • "Potentially novel miRNAs were identified using miRDeep2 (v2.0.0.5) [17]. The predicted novel miRNAs that were independently predicted in at least three samples and fulfilled all of the following criteria were submitted to miRBase: the mature sequence was expressed in at least ten samples and was expressed at a minimum of 100 reads per million (RPM); the predicted miRNA had a high (>90%) probability of being a true miRNA according to miRDeep2; and the hairpin structure had a RandFold P value <0.05. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium bovis, the causative agent of bovine tuberculosis, a major problem for global agriculture, spreads via an airborne route and is taken up by alveolar macrophages (AM) in the lung. Here, we describe the first next-generation sequencing (RNA-seq) approach to temporally profile miRNA expression in primary bovine AMs post-infection with M. bovis. One, six, and forty miRNAs were identified as significantly differentially expressed at 2, 24 and 48 h post-infection, respectively. The differential expression of three miRNAs (bta-miR-142-5p, bta-miR-146a, and bta-miR-423-3p) was confirmed by RT-qPCR. Pathway analysis of the predicted mRNA targets of differentially expressed miRNAs suggests that these miRNAs preferentially target several pathways that are functionally relevant for mycobacterial pathogenesis, including endocytosis and lysosome trafficking, IL-1 signalling and the TGF-β pathway. Over-expression studies using a bovine macrophage cell-line (Bomac) reveal the targeting of two key genes in the innate immune response to M. bovis, IL-1 receptor-associated kinase 1 (IRAK1) and TGF-β receptor 2 (TGFBR2), by miR-146. Taken together, our study suggests that miRNAs play a key role in tuning the complex interplay between M.bovis survival strategies and the host immune response.
    Full-text · Article · Feb 2015 · Tuberculosis
  • Source
    • "Primary data analysis was done using the Illumina CASAVA Pipeline software v.1.8.2, and the sequence reads were further processed by trimming for adapters and filtering for low quality using Trimmomatic (Lohse et al., 2012). Identification of conserved and novel candidate microRNA genes in the bowhead genome was accomplished by applying the miRDeep2 algorithm (Friedlä nder et al., 2008, 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graphical Abstract Highlights d Genome and two transcriptomes of the bowhead whale, the longest-lived mammal d Bowhead-specific mutations in genes associated with cancer and aging (e.g., ERCC1) d Duplications in genes associated with DNA repair, cell cycle, and aging (e.g., PCNA) d Changes in genes related to thermoregulation (UCP1) and other bowhead traits Correspondence In Brief The bowhead whale is the longest-lived mammal, possibly living over 200 years. Keane et al. sequence the bowhead genome and transcriptome and perform a comparative analysis with other cetaceans and mammals. Changes in bowhead genes related to cell cycle, DNA repair, cancer, and aging suggest alterations that may be biologically relevant.
    Full-text · Article · Jan 2015 · Cell Reports
Show more